Potomac Analytics' Logo

Broker-Dealers on SEC Form D for AEGIS CAPITAL CORP.

Form Ds provide information on individual, unregistered securities offerings.

Search by Recipient Name or Primary Issuer:

Filter by:

Sort by:

Displaying 191-200 out of 355 results
Recipient CRD Primary Issuer CIK Filing Date Form Type Total Offering Amount Total Amount Sold
AEGIS CAPITAL CORP.15007ORGANOVO HOLDINGS, INC.149725301/04/2013D$7,662,675$7,662,675
AEGIS CAPITAL CORP.15007Matinas BioPharma Holdings, Inc.158255408/07/2013D$15,000,000$7,593,750
AEGIS CAPITAL CORP.15007HYDROFARM HOLDINGS GROUP, INC.169529512/17/2019D$10,000,000$7,531,840
AEGIS CAPITAL CORP.15007GLOBEIMMUNE INC124510402/13/2014D$7,500,000$7,500,000
AEGIS CAPITAL CORP.15007GLOBEIMMUNE INC124510406/10/2014D/A$7,500,000$7,500,000
AEGIS CAPITAL CORP.15007AmCap Necessity Retail Fund LLC176632703/06/2020D/A$100,000,000$7,425,000
AEGIS CAPITAL CORP.15007Aegis Special Situations Fund LLC - Series Medtech IX194182108/30/2022D$10,000,000$7,185,000
AEGIS CAPITAL CORP.15007Crescent Moon Investors, LLC175992511/26/2018D$7,010,000$7,010,000
AEGIS CAPITAL CORP.15007Agritech Partners LLC - Series HB-1186694806/11/2021D$40,000,000$6,610,000
AEGIS CAPITAL CORP.15007Corbus Pharmaceuticals Holdings, Inc.159509704/23/2014D$13,000,000$6,310,000

355 Results

Display: